Structure |
Chemical Name |
CAS |
MF |
|
EzetiMibe ring-opening dehydrate iMpurity |
1292292-63-7 |
C24H21F2NO3 |
|
Fondaparinux sodiuM iMpurity 1 |
348625-84-3 |
C13H21NO19S3 |
|
Pitavastatin IMpurity 4 (PP-4) |
1422058-54-5 |
C25H22FNO3 |
|
Pregabalin IMpurity |
159029-27-3 |
C7H18N2 |
|
Valdecoxib 3'-SulfonaMide IMpurity |
1373038-56-2 |
C16H14N2O3S |
|
(3R,4R)-4-(2,5-Difluorophenyl)-3-Methyl-4-(1H-1,2,4-triazol-1-ylMethyl)-2-oxetanone |
483340-20-1 |
C13H11F2N3O2 |
|
6,7-DiMethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one |
1177261-73-2 |
C19H24N4O5 |
|
13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid |
229312-33-8 |
C13H22N4O5 |
|
rac-Clopidogrel Carboxylic Acid Hydrochloride |
1015247-88-7 |
C15H15Cl2NO2S |
|
Milnacipran IMpurity |
810696-16-3 |
C11H11NO |
|
Terbutaline IMpurity 8 |
28924-20-1 |
C26H30BrNO3 |
|
Etoricoxib IMpurity |
1350206-14-2 |
C18H16N2O2S |
|
(1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate |
929693-31-2 |
C15H28N2O6S |
|
4-ヒドロキシ-7-メトキシキノリン-6-カルボアミド |
417724-81-3 |
C11H10N2O3 |
|
Tegafur Impurity BCB |
|
|
|
((2R,3R,4R)-3-(benzoyloxy)-4-chloro-4-Methyl-5-oxotetrahydrofuran-2-yl)Methyl benzoate |
1496551-65-5 |
C20H17ClO6 |
|
2-(4-fluorophenyl)-5-(2-Methylbenzyl)thiophene |
2005454-69-1 |
C18H15FS |
|
AcetaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- |
1429334-00-8 |
C16H19N3O5 |
|
PSI 7411 |
1015073-43-4 |
C10H14FN2O8P |
|
5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-(1-methylethyl)-2-oxazolidinone |
1071765-44-0 |
C14H19NO4 |
|
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-tetrakis(2,2-dimethylpropanoate) |
1283129-18-9 |
C44H57FO9S |
|
1,4′-ビピペリジン-1′-カルボン酸 |
1026078-50-1 |
C11H20N2O2 |
|
4-[[3-(1-Methylethyl)-2-oxo-5-oxazolidinyl]methoxy]benzaldehyde |
1173203-26-3 |
C14H17NO4 |
|
EMpagliflozin iMpurity 9 |
|
|
|
EMpagliflozin iMpurity 14 |
2137418-13-2 |
C23H27ClO8 |
|
ibrutinib iMpurity A |
|
|
|
Sunitinib iMpurity E |
|
|
|
Rosuvastatin EP impurity H |
1335110-44-5 |
C22H28FN3O6S |
|
Saxagliptin Impurity 4 (Deoxy Saxagliptin) |
|
|
|
Betamethasone EP Impurity D |
52619-05-3 |
C25H33FO7 |
|
Dihydropenicillin F Potassium Salt |
31447-86-6 |
C14H23KN2O4S |
|
Etoricoxib Impurity 7 |
646459-39-4 |
C20H21N3O2S |
|
Mupirocin Impurity D |
|
C26H44O9 |
|
Phenylephrine EP Impurity D |
1367567-95-0 |
C16H19NO2 |
|
Verapamil Impurity O |
959011-16-6 |
C27H38N2O4 |
|
1,1′-(イソプロピルイミノ)ビス[3-[4-(2-メトキシエチル)フェノキシ]-2-プロパノール] |
1486464-40-7 |
C27H42ClNO6 |
|
4'-FLUOROCYCLOPROPANECARBOXANILIDE |
2354-89-4 |
C10H10FNO |
|
(Z)-2-(2-Aminothiazol-4-yl)-2-(1-carboxy-1-methyl)ethoxyiminoacetic acid |
102507-85-7 |
C9H11N3O5S |
|
Cefaclor EP IMpurity |
|
|
|
Linagliptin Impurity F |
1673546-62-7 |
C27H27F3N8O3 |
|
Parecoxib Impurity D |
|
|
|
Parecoxib Impurity I |
|
|
|
Lenvatinib Impurity d |
417717-04-5 |
C20H17ClN4O4 |
|
4-ブロモ-3-(ヒドロキシメチル)フェノール |
2737-20-4 |
C7H7BrO2 |
|
4-(4-Bromo-3-formyl-phenoxy)-benzonitrile |
906673-54-9 |
C14H8BrNO2 |
|
Linagliptin Impurity I |
|
|
|
1H-Pyrrole-3-carbonitrile,5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)- |
1807642-39-2 |
C16H10FN3O2S |
|
4-amino-1-[(2RS)-2-(2,4-difluorophenyl)-2-hydroxy-3(1H-
1,2,4-triazol-1-yl)propyl]-4H-1,2,4-triazolium |
749821-19-0 |
C13H14F2N7O+ |
|
Canagliflozin Defluoro Impurity |
|
|
|
Dapagliflozin Impurity 6 |
|
|
|
Imatinib Impurity 7 |
581076-64-4 |
C8H12N4 |
|
Nilotinib Impurity 1 |
641571-05-3 |
C28H22F3N7O |
|
Riociguat Impurtiy 1 |
|
|
|
Riociguat Impurtiy 6 |
1702271-98-4 |
C18H17FN8 |
|
Brimonidine Impurity E |
168329-48-4 |
C9H8BrN5 |
|
Dapagliflozin Impurity G |
|
|
|
Dapoxetine Impurity B |
|
|
|
Fesoterodine Diol Dimer |
1428856-45-4 |
C44H60N2O3 |
|
Gimeracil Impurity |
17902-24-8 |
C8H9ClN2O3 |
|
Pramipexole Impurity H |
|
|
|
Rivaroxaban Impurity H |
1807455-76-0 |
C25H24Cl2N4O6S2 |
|
Vonoprazan impurity A |
|
|
|
5-ethyl 3-isopropyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
2170716-02-4 |
C22H29ClN2O5 |
|
Ibrutinib impurity D |
|
|
|
Mupirocin impurity A |
|
C26H44O9 |
|
FG-4592 intermediate7 |
1509958-19-3 |
C20H20N2O4 |
|
Milnacipran Impurity 13 |
710339-49-4 |
C12H16NO+ |
|
Urapidil Impurity A |
|
|
|
Tofacitinib Impurity I |
|
|
|
N-(3-chloro-4-fluorophenyl)-6 ,7-dimethoxyquinazolin-4-amine |
153437-78-6 |
C16H13ClFN3O2 |
|
N-[4-[2-(メチルアミノ)エトキシ]ベンジル]-3,4-ジメトキシベンズアミド |
141996-97-6 |
C19H24N2O4 |
|
Mirabegron Impurity |
1796931-48-0 |
C21H24N4O2S |
|
34-Methylcyanocobalamin |
38218-51-8 |
C64H90CoN14O14P |
|
Empagliflozin Impurity D |
|
|
|
Ipragliflozin Impurity 2 |
|
|
|
Nicergoline EP impurity F |
|
|
|
Mirabegron Impurity 4 |
|
|
|
Bisoprolol EP Impurity D |
1225195-71-0 |
C26H40N2O5 |
|
2-(4-イソブトキシフェニル)-4-メチルチアゾール-5-カルボン酸 |
1206550-99-3 |
C15H17NO3S |
|
(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,5,6,7,8,9,10,11,12,13,15,16-dodecahydro-4H-cyclopenta[a]phenanthren-17(14H)-one |
14639-79-3 |
C19H28O |
|
Cefuroxime Sodium Impurity |
|
C16H16N4NaO8S |
|
2-Bromo (S)-Carbidopa |
43197-33-7 |
C10H13BrN2O4 |
|
Eliglustat intermediate 3 |
491833-26-2 |
C23H28N2O5 |
|
Aztreonam Impurity B |
102586-36-7 |
C13H19N5O6S |
|
Olopatadine impurity |
|
|
|
Voriconazole Impurity 8 |
239807-03-5 |
C16H14F3N5O |
|
Caspofungin impurity 3 |
|
|
|
Plerixafor Impurity D |
|
|
|
Cefuroxime impurity 1 |
|
C16H16N4O8S |
|
Vonoprazan Impurity 9 |
|
|
|
Sitagliptin IMpurity 5 |
|
|
|
Brexpiprazole Impurity3 |
|
|
|
Levetiracetam impurity 5 |
1543300-90-8 |
C9H17NO4 |
|
Febuxostat Impurity B |
|
|
|
Sorafenib Impurity F |
|
|
|
Trelagliptin Impurity 1 |
1821400-07-0 |
C21H13ClF2N4O2 |
|
Vortioxetine Imp.J |
2137588-68-0 |
C18H22N2S |
|
4-amino-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
1608459-56-8 |
C18H27N3O3 |
|
4,5-dichloro Rivaroxaban |
2305917-61-5 |
C25H28ClN3O6S |
|
Solifenacin EP Impurity B |
1534326-81-2 |
C31H28N2O |